There’s certainly plenty of demand for and hype around the new wave of weight loss agents. But insurers are pulling back on coverage of these products.
New Classes Of Obesity Drugs Face Strong Headwinds From Insurers
There’s certainly plenty of demand for and hype around the new wave of weight loss agents. But insurers are pulling back on coverage of these products.